NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Lykos Therapeutics

Lykos Therapeutics

Private
San Jose, CaliforniaHealthcare & Life Scienceshttps://lykospbc.com/

Last Round

Series B

May 30, 2025

Total Funding Raised

$150M

Company Overview

Lykos Therapeutics is a pharmaceutical company focused on the research and development of psychedelic medicines and therapies to treat mental health conditions, with an initial focus on post-traumatic stress disorder (PTSD).

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Mental Health

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

MDMA-assisted therapypsychedelic medicinePTSD treatmentpsychedelicsbiopharmaceuticalpublic benefit corporationPBCclinical trialsFDA approvalmental healththerapist trainingdrug development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lykos Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Lykos Therapeutics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Lykos Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMay 30, 2025
Series AJan 5, 2024

Lykos Therapeutics Investors

Notable investors and investment history

Lykos Therapeutics investors
InvestorRounds
Vine VenturesSeries A
Steven & Alexandra Cohen FoundationSeries A
Bail CapitalSeries A
Wisdom VenturesSeries A
KittyHawk VenturesSeries A
Helena Special InvestmentsSeries A
Tabula Rasa VenturesSeries A

Lykos Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Lykos Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Lykos Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Jose, California
Employee Range67
Year Founded2014
Last FundingMay 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.